Internal Medicine · Neenah, WI
NPI
1629097654
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1524 S Commercial St Ste 2n
Neenah, WI, 54956
Phone (844) 547-4343
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
176 services
Medicare patients, 2024
146
Average age 71
Drug cost, 2024
$2.0M
3,301 prescriptions
Company payments, 2025
$172
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ann M Liebeskind was code 99215 (office e&m - established), 120 times for 104 patients. In total Ann M Liebeskind billed 176 services in 4 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 120 | 104 | $116.70 | $14K |
| 99214 Office E&M - Established | Office | 43 | 41 | $75.72 | $3,256 |
By year: 2022 $14K for 140 services; 2023 $17K for 173 services; 2024 $18K for 176 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ann M Liebeskind prescribed most often to Medicare patients was Repatha Sureclick (Evolocumab), with 1,885 prescriptions and refills. In total Ann M Liebeskind wrote 3,301 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Repatha Sureclick Evolocumab | 1,885 | 2,746 | 267 | $1.5M |
| Praluent Pen Alirocumab | 343 | 550 | 60 | $277K |
| Ezetimibe Generic | 310 | 833 | 86 | $6,346 |
| Rosuvastatin Calcium Generic | 228 | 641 | 79 | $2,578 |
| Vascepa Icosapent Ethyl | 126 | 242 | 30 | $85K |
| Atorvastatin Calcium Generic | 72 | 187 | 24 | $711 |
| Icosapent Ethyl Generic | 70 | 176 | 22 | $33K |
| Fluvastatin Sodium Generic | 65 | 163 | 18 | $9,513 |
| Fenofibrate Generic | 42 | 95 | Under 11 | $665 |
| Repatha Syringe Evolocumab | 37 | 41 | Under 11 | $23K |
| Nexletol Bempedoic Acid | 30 | 50 | 11 | $20K |
| Fenofibrate Fenofibrate Nanocrystallized | 22 | 46 | Under 11 | $534 |
| Omega-3 Acid Ethyl Esters Generic | 20 | 48 | Under 11 | $2,518 |
| Pravastatin Sodium Generic | 16 | 42 | Under 11 | $292 |
| Metformin Hcl Er Metformin Hcl | 14 | 25 | Under 11 | $49.46 |
Brand drugs: 2,425 claims; generic drugs: 876 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ann M Liebeskind $172 ($172 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $172.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $172 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.